These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20304068)

  • 21. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer and epigenesis: a developmental perspective.
    Oligny LL
    Adv Pediatr; 2003; 50():59-80. PubMed ID: 14626483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics in human disease and prospects for epigenetic therapy.
    Egger G; Liang G; Aparicio A; Jones PA
    Nature; 2004 May; 429(6990):457-63. PubMed ID: 15164071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental origins of diabetes: the role of epigenetic mechanisms.
    Simmons RA
    Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):13-6. PubMed ID: 17940413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
    Ke X; Lei Q; James SJ; Kelleher SL; Melnyk S; Jernigan S; Yu X; Wang L; Callaway CW; Gill G; Chan GM; Albertine KH; McKnight RA; Lane RH
    Physiol Genomics; 2006 Mar; 25(1):16-28. PubMed ID: 16380407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia.
    Perkins DO; Jeffries C; Sullivan P
    Mol Psychiatry; 2005 Jan; 10(1):69-78. PubMed ID: 15381925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The A140V mutation in the MECP2 gene is not a common etiological factor among Brazilian mentally retarded males.
    dos Santos JM; Abdalla CB; Campos M; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2005 Apr; 379(1):13-6. PubMed ID: 15814190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic regulation in the pathophysiology of Alzheimer's disease.
    Chouliaras L; Rutten BP; Kenis G; Peerbooms O; Visser PJ; Verhey F; van Os J; Steinbusch HW; van den Hove DL
    Prog Neurobiol; 2010 Apr; 90(4):498-510. PubMed ID: 20097254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation in mammalian oocytes of gene transcripts linked to epigenetic reprogramming.
    Oliveri RS; Kalisz M; Schjerling CK; Andersen CY; Borup R; Byskov AG
    Reproduction; 2007 Oct; 134(4):549-58. PubMed ID: 17890290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylomes, histone codes and miRNAs: tying it all together.
    Guil S; Esteller M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.
    Vermeulen M; Eberl HC; Matarese F; Marks H; Denissov S; Butter F; Lee KK; Olsen JV; Hyman AA; Stunnenberg HG; Mann M
    Cell; 2010 Sep; 142(6):967-80. PubMed ID: 20850016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyl-CpG-binding protein 2 (MECP2) gene mutations in an Italian sample of patients with pervasive developmental disorder and mental retardation.
    Parmeggiani A; Tedde MR; Arbizzani A; Posar A; Scaduto MC; Santucci M; Sangiorgi S
    J Child Neurol; 2009 Jun; 24(6):772-4. PubMed ID: 19189931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O; Herman JG; Baylin SB
    Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
    Csoka AB; Szyf M
    Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic impacts on neurodevelopment: pathophysiological mechanisms and genetic modes of action.
    Zahir FR; Brown CJ
    Pediatr Res; 2011 May; 69(5 Pt 2):92R-100R. PubMed ID: 21293311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.